首頁 > 市場調查報告書 > 製藥

骨疾病

骨關節炎治療市場規模、佔有率和成長分析（按解剖部位、藥物類型、治療類型、通路和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1896785

骨關節炎治療市場規模、佔有率和成長分析（按解剖部位、藥物類型、治療類型、通路和地區分類）－2026-2033年產業預測

Osteoarthritis Treatment Market Size, Share, and Growth Analysis, By Anatomy, By Drug Type (Analgesics, Nonsteroidal Anti-Inflammatory Drugs ), By Treatment Type, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，骨關節炎治療市場規模將達到 94.5 億美元，到 2025 年將達到 102.5 億美元，到 2033 年將達到 196.9 億美元，預測期（2026-2033 年）的複合年成長率為 8.5%。

由於骨關節炎發生率上升和人口老化，骨關節炎治療市場正經歷強勁成長，對有效治療方案的需求也隨之增加。隨著預期壽命的延長，骨關節炎高風險族群數量也在迅速成長，凸顯了創新治療方法在改善患者預後和生活品質方面的必要性。此外，人們對現有治療方法和早期療育重要性的認知不斷提高，也顯著促進了市場擴張。醫療機構正日益重視對患者進行骨關節炎相關知識、風險因素和各種治療方案的教育，從而加速診斷和治療啟動。這種日益成長的認知正在推動對骨關節炎治療產品的需求，預計未來幾年將持續推動市場成長。

骨關節炎治療司機

全球肥胖率的上升是骨關節炎發生率上升的重要原因之一。隨著肥胖人群的增多，骨關節炎病例也相應增加。這一趨勢導致對有效治療方案的需求日益成長，因為肥胖患者通常需要採取全面的管理策略來控制病情。因此，醫療保健機構和製造商不得不探索和開發各種治療方案，以滿足不斷成長的患者群體的需求。由此可見，肥胖與骨關節炎之間的相互關係正在顯著影響骨關節炎治療市場的趨勢。

骨關節炎治療市場的限制因素

骨關節炎治療的一大障礙是缺乏有效的疾病修正治療（DMT）。儘管各種治療方案取得了進展，但缺乏能夠延緩或逆轉骨關節炎進展的有效治療方法仍然是一項重大挑戰。這種療法的匱乏不僅使疾病管理更加複雜，而且對患者預後產生負面影響，並限制了治療選擇。因此，亟需在該領域尋求創新解決方案，以改善患者預後並提高綜合骨關節炎治療策略的有效性。

骨關節炎治療市場趨勢

骨關節炎治療領域的一個顯著市場趨勢是轉向個人化、多面向的管理策略。隨著這種退化性關節疾病的盛行率不斷上升，尤其是在老年人族群中，醫療專業人員正在拋棄傳統的疼痛管理方法，例如非類固醇消炎劑（NSAIDs）和鎮痛藥。取而代之的是，他們正在採用結合藥物和非藥物療法（包括物理治療、營養指導和再生醫學等先進干預措施）的個人化治療方案。這種綜合辦法旨在應對骨關節炎的複雜性，透過認知到個別患者的需求和治療反應可能存在顯著差異，從而提高整體療效和患者滿意度。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Sanofi（France）
Pfizer Inc.（USA）
Novartis AG（Switzerland）
Johnson & Johnson（USA）
GlaxoSmithKline plc（UK）
AbbVie Inc.（USA）
Eli Lilly and Company（USA）
Bayer AG（Germany）
Merck & Co., Inc.（USA）
Bristol Myers Squibb（USA）
AstraZeneca plc（UK）
Amgen Inc.（USA）
Haleon plc（UK）
Seikagaku Corporation（Japan）
Ono Pharmaceutical Co., Ltd.（Japan）
Assertio Holdings, Inc.（USA）
Zimmer Biomet Holdings, Inc.（USA）
Ferring Pharmaceuticals（Switzerland）
Genascence Corporation（USA）

結論與建議

簡介目錄

Product Code: SQMIG35A2305

Osteoarthritis Treatment Market size was valued at USD 9.45 Billion in 2024 and is poised to grow from USD 10.25 Billion in 2025 to USD 19.69 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The osteoarthritis treatment market is experiencing robust growth, fueled by a rising incidence of the condition and a growing elderly population, which increases the demand for effective management solutions. As life expectancy improves, the number of individuals at risk for osteoarthritis has also surged, highlighting the need for innovative treatment approaches that enhance patient outcomes and quality of life. Additionally, heightened awareness around available therapies and the importance of early intervention is significantly influencing market expansion. Healthcare providers are increasingly focused on educating patients about osteoarthritis, associated risk factors, and diverse treatment options, resulting in more timely diagnoses and treatment initiation. This heightened awareness is driving demand for osteoarthritis treatment products, positioning the market for sustained growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Osteoarthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Osteoarthritis Treatment Market Segments Analysis

Global Osteoarthritis Treatment Market is segmented by anatomy, drug type, treatment type, distribution channel and region. Based on anatomy, the market is segmented into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis and small joint osteoarthritis. Based on drug type, the market is segmented into analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, visco supplementation agents and others. Based on treatment type, the market is segmented into medication, surgery and therapy. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Osteoarthritis Treatment Market

The rising global prevalence of obesity plays a crucial role in the growing incidence of osteoarthritis. As more individuals struggle with obesity, the number of osteoarthritis cases correspondingly increases. This trend leads to a heightened demand for effective treatment solutions, as those affected by obesity often need extensive management strategies to address their condition. Consequently, healthcare providers and manufacturers are compelled to explore and develop a range of therapeutic options to meet the needs of this expanding patient population. Thus, the interconnection between obesity and osteoarthritis significantly influences the dynamics within the osteoarthritis treatment market.

Restraints in the Osteoarthritis Treatment Market

A key obstacle in the osteoarthritis treatment landscape is the unavailability of disease-modifying therapies. Although there have been advancements in various treatment options, the deficit of effective therapies that can slow or reverse the progression of osteoarthritis poses a considerable challenge. This shortfall not only complicates the overall management of the condition but also adversely affects the results for patients, leaving them with limited alternatives for their care. The need for innovative solutions in this area is critical to improve patient outcomes and enhance the effectiveness of overall treatment strategies for osteoarthritis.

Market Trends of the Osteoarthritis Treatment Market

A notable market trend in the Osteoarthritis Treatment sector is the shift towards personalized and multimodal management strategies. As the prevalence of this degenerative joint disease rises, particularly among the aging population, healthcare professionals are moving beyond conventional pain management techniques, such as NSAIDs and analgesics. Instead, they are adopting tailored treatment plans that incorporate a blend of pharmacologic and non-pharmacologic therapies, including physical therapy, nutritional guidance, and advanced interventions like regenerative medicine. This holistic approach aims to address the complex nature of osteoarthritis, recognizing that individual patient needs and responses to treatment can vary significantly, thus enhancing overall efficacy and patient satisfaction.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis

Global Osteoarthritis Treatment Market Size by Anatomy & CAGR (2026-2033)

Market Overview
Knee Osteoarthritis
Hip Osteoarthritis
Hand Osteoarthritis
Small Joint Osteoarthritis

Global Osteoarthritis Treatment Market Size by Drug Type & CAGR (2026-2033)

Market Overview
Analgesics
- Acetaminophen
- Opioids
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Ibuprofen
- Naproxen
Corticosteroids
- Oral Corticosteroids
- Injectable Corticosteroids
Visco Supplementation Agents
- Hyaluronic Acid
Others
- Disease-Modifying Osteoarthritis Drugs (DMOADs)

Global Osteoarthritis Treatment Market Size by Treatment Type & CAGR (2026-2033)

Market Overview
Medication
Surgery
- Joint Replacement
- Arthroscopy
- Osteotomy
Therapy
- Physical Therapy
- Occupational Therapy

Global Osteoarthritis Treatment Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Osteoarthritis Treatment Market Size & CAGR (2026-2033)

North America (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- US
- Canada
Europe (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Anatomy, Drug Type, Treatment Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haleon plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seikagaku Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ono Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Assertio Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet Holdings, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genascence Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments